Clinical trials in the UK which prove the effectiveness of PBM (Photobiomodulation Therapy) – otherwise known as Low Level Laser Therapy – look set to increase. Last year NICE (National Institute for Health and Care Excellence) approved therapeutic laser for oral mucositis (OM), one of the common side effects caused by radiotherapy and chemotherapy for cancer patients. Clinicians at Southampton University Hospital carried out clinical trials to show the effectiveness of using therapeutic laser for oral mucositis, to prevent this a side effect from radiotherapy and chemotherapy, and / or to treat the symptoms of oral mucositis, which include inflammation and pain. NICE subsequently approved low-level laser as a safe and effective treatment.

Therapeutic Laser is used to treat many inflammatory conditions and is effective in management of acute and chronic pain. In America the FDA has approved low-level laser for many conditions, and we hope to see NICE do the same in the UK.

Read more about the Southampton University low-level research trial here.